Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinoma

References

• Chen J, Wang W, Zhang Y, et al. (2014a). Predicting distant metastasis and chemoresistance using plasma miRNAs. Med Oncol 31:799. doi: 10.1007/s12032-013-0799-x.
   PubMed Web of Science ®Google Scholar
• Chen P, Wang BL, Pan BS, Guo W. (2014b). MiR-1297 regulates the growth, migration and invasion of colorectal cancer cells by targeting cyclo-oxygenase-2. Asian Pac J Cancer Prev 15:9185–90.
   PubMedGoogle Scholar
• Cho WC. (2007). OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6:60. doi: 10.1186/1476-4598-6-60.
   PubMed Web of Science ®Google Scholar
• Dong W, Li B, Wang Z, et al. (2015). Clinical significance of microRNA-24 expression in esophageal squamous cell carcinoma. Neoplasma 62:250–8.
   PubMed Web of Science ®Google Scholar
• Feng XS, Yang YT, Gao SG, et al. (2014). Prevalence and age, gender and geographical area distribution of esophageal squamous cell carcinomas in North China from 1985 to 2006. Asian Pac J Cancer Prev 15:1981–7.
   PubMedGoogle Scholar
• Garzon R, Calin GA, Croce CM. (2009). MicroRNAs in cancer. Annu Rev Med 60:167–79.
   PubMed Web of Science ®Google Scholar
• Hezova R, Kovarikova A, Srovnal J, et al. (2015). Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus. Diagn Pathol 10:42. doi: 10.1186/s13000-015-0280-6.
   PubMed Web of Science ®Google Scholar
• Jiang L, Wang Y, Rong Y, et al. (2015). miR-1179 promotes cell invasion through SLIT2/ROBO1 axis in esophageal squamous cell carcinoma. Int J Clin Exp Pathol 8:319–27.
   PubMed Web of Science ®Google Scholar
• Komatsu S, Ichikawa D, Hirajima S, et al. (2014). Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma. Br J Cancer 111:1614–24.
   PubMed Web of Science ®Google Scholar
• Lee KH, Goan YG, Hsiao M, et al. (2009). MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp Cell Res 315:2529–38.
   PubMed Web of Science ®Google Scholar
• Li X, Wang HL, Peng X, et al. (2012). miR-1297 mediates PTEN expression and contributes to cell progression in LSCC. Biochem Biophys Res Commun 427:254–60.
   PubMed Web of Science ®Google Scholar
• Lin C, Huang F, Li QZ, Zhang YJ. (2014). miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells. Int J Clin Exp Pathol 7:6543–50.
   PubMed Web of Science ®Google Scholar
• Liu R, Peng Y, Li X, et al. (2013). Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform. Int J Mol Sci 14:8899–911.
   PubMed Web of Science ®Google Scholar
• Liu F, He Y, Shu R, Wang S. (2015). MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2. Int J Clin Exp Pathol 8:4972–80.
   PubMed Web of Science ®Google Scholar
• Lovat F, Valeri N, Croce CM. (2011). MicroRNAs in the pathogenesis of cancer. Semin Oncol 38:724–33.
   PubMed Web of Science ®Google Scholar
• Mar-Aguilar F, Mendoza-Ramirez JA, Malagon-Santiago I, et al. (2013). Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Disease Markers 34:163–9.
   PubMed Web of Science ®Google Scholar
• Napier KJ, Scheerer M, Misra S. (2014). Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol 6:112–20.
   PubMed Web of Science ®Google Scholar
• Ng EK, Chong WW, Jin H, et al. (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58:1375–81.
   PubMed Web of Science ®Google Scholar
• Ouyang M, Li Y, Ye S, et al. (2014). MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer. PLoS One 9:e96228. doi: 10.1371/journal.pone.0096228.
   PubMed Web of Science ®Google Scholar
• Pennathur A, Gibson MK, Jobe BA, Luketich JD. (2013). Oesophageal carcinoma. Lancet 381:400–12.
   PubMed Web of Science ®Google Scholar
• Reddy KB. (2015). MicroRNA (miRNA) in cancer. Cancer Cell Int 15:38. doi: 10.1186/s12935-015-0185-1.
   PubMed Web of Science ®Google Scholar
• Sempere LF. (2011). Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer. Expert Rev Mol Diagn 11:813–27.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Miyata H, Yamasaki M, et al. (2013). Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. Ann Surg Oncol 20:S607–15.
   Web of Science ®Google Scholar
• Wang RJ, Zheng YH, Wang P, Zhang JZ. (2015). Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. Int J Clin Exp Pathol 8:765–71.
   PubMed Web of Science ®Google Scholar
• Wu C, Li M, Hu C, Duan H. (2014). Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. Mol Biol Rep 41:1257–66.
   PubMed Web of Science ®Google Scholar
• Xiang M, Zeng Y, Yang R, et al. (2014). U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochem Biophys Res Commun 454:210–14.
   PubMed Web of Science ®Google Scholar
• Yang NQ, Zhang J, Tang QY, et al. (2014). miRNA-1297 induces cell proliferation by targeting phosphatase and tensin homolog in testicular germ cell tumor cells. Asian Pac J Cancer Prev 15:6243–6.
   PubMedGoogle Scholar
• Yang JS, Li BJ, Lu HW, et al. (2015). Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening. Tumour Biol 36:3035–42.
   PubMed Web of Science ®Google Scholar
• Zhang C, Chi YL, Wang PY, et al. (2012a). miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2. PLoS One 7:e46090. doi: 10.1371/journal.pone.0046090.
   Google Scholar
• Zhang J, Xv Z, Wu X, Li K. (2012b). Potential diagnostic value of serum p53 antibody for detecting esophageal cancer: a meta-analysis. PLoS One 7:e52896. doi: 10.1371/journal.pone.0052896.
   PubMed Web of Science ®Google Scholar
• Zhang F, Yang Z, Cao M, et al. (2014). MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer. Cancer Lett 342:121–9.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhu Z, Liu Y, et al. (2015). Diagnostic value of multiple tumor markers for patients with esophageal carcinoma. PLoS One 10:e0116951. doi: 10.1371/journal.pone.0116951.
   PubMed Web of Science ®Google Scholar
• Zheng X, Xing S, Liu XM, et al. (2014). Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma. BMC Cancer 14:490. doi: 10.1186/1471-2407-14-490.
   PubMed Web of Science ®Google Scholar
• Zhou JH, Zhang B, Kernstine KH, Zhong L. (2011). Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma. World J Gastroenterol 17:1373–8.
   PubMed Web of Science ®Google Scholar